Safety and Efficacy Study of Epcoritamab in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia and Richter's Syndrome

Clinical trial NCT04623541 · ACTIVE_NOT_RECRUITING

Trial details

NCT number

NCT04623541

Sponsor

Genmab

Status

ACTIVE_NOT_RECRUITING

Phase

Phase 1, Phase 2

Study type

INTERVENTIONAL

Start date

2020-11-25

Primary completion

2027-12-01

Enrollment

194

View on ClinicalTrials.gov